SciELO - Scientific Electronic Library Online

 
vol.32 issue3Vectocardiographic analysis of right ventricular electrical conduction delayRisk of cardiovascular disease in soccer referees: a cross sectional study author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

article

Indicators

Share


Journal of Human Growth and Development

Print version ISSN 0104-1282On-line version ISSN 2175-3598

J. Hum. Growth Dev. vol.32 no.3 Santo André Sept./Dec. 2022  Epub Jan 20, 2025

https://doi.org/10.36311/jhgd.v32.13328 

ORIGINAL ARTICLE

Mortality attributable to cardiovascular diseases in young adults residents in Brazil

Silmara Lira Ribeiroa 

Hugo Macedo Ferraz e Souza Júniora  b 

Fernando Adamia  b 

Edigê Felipe de Sousa Santosc 

Henrique sde Moraes Bernala 

Tassiane Cristina de Moraisd 

Fabiana Rosa Neves Smiderled 

Renata Macedo Martins Pimentela 

Daniel Paulino Venâncioe 

aLaboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário FMABC, Santo André, SP, Brasil;

bDepartamento de Saúde da Coletividade, Centro Universitário FMABC, Santo André, SP, Brasil;

cDepartamento de Epidemiologia. Faculdade de Saúde Pública. Universidade de São Paulo (USP), São Paulo, SP, Brasil;

dDepartamento de pós graduação, mestrado em Politicas Públicas e Desenvolvimento Local,Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória, EMESCAM, Vitória, Espírito Santo, Brasil;

eDepartamento de Morfologia e Fisiologia, Centro Universitário FMABC, Santo André, SP, Brasil.


Authors summary

Why was this study done?

Population-based epidemiological studies on cause-specific mortality allow directing public policies towards population risk. Few studies address how regional differences attributed to socioeconomic factors affect mortality from cardiovascular diseases in younger populations. Detailed analysis of CVD mortality trends can help to identify determinants and, therefore, highlight population subgroups, which are at risk for developing chronic diseases and which may benefit from targeted treatment and prevention.

What did the researchers do and find?

An ecological time series study was carried out using official secondary data from the Mortality Information Systems (SIM). 294,232 deaths from cardiovascular diseases were considered by the International Classification of Diseases (I00-I-99) in young adults aged between 20-49 years, residing in Brazil, in the period from 01/01/2008 to December 31, 2017. There are a decreasing trend in mortality from Cardiovascular Disease (CVD) in young adults in Brazil. In addition, a regional difference in mortality was identified according to regions of Brazil. In addition, mortality in females declined in both periods in the Central-West and South regions, while mortality remained stationary in the North, Northeast and Southeast regions in the period (2013-2017), where in this period the mortality trend stabilized to both sexes in the North and Northeast regions. There was an increase only in the Northeast region aged 20-24 years, period (2013-2017).

What do these findings mean?

The findings contribute to the planning and management of the Primary Health Care system. Young Brazilians should not progress to death from CVD, as their vital capacity is higher than that of the elderly. Measures for the early detection of causal factors will contribute to the reduction of deaths.

Key words: cardiovascular diseases; epidemiology; mortality; young adult

Abstract

Introduction

cardiovascular diseases are the leading causes of death in the world. Despite the reduction in CVD incidence and mortality in the 20th century, the values remain high in the 21st century. In Brazil, there is a gap in population studies that estimated standardized mortality rates from cardiovascular diseases in young adults.

Objective

to assess the trend in mortality from cardiovascular diseases in young adults, according to sex, age group and regions of Brazil.

Methods

ecological time series study using official secondary data from Mortality Information Systems (SIM). All deaths from cardiovascular diseases (I00-I-99) in young adults aged 20-49 years, residing in Brazil, in the period from January 1, 2008 to December 31, 2017, were considered. Data were extracted from the Department of Informatics of the SUS (DATASUS). The Prais-Winsten regression model was used and the Annual Percentage Variation (APV) was calculated. All analyzes were performed in STATA 14.0 software.

Results

during the period 2008-2017, 294,232 deaths (8.7%) from cardiovascular disease were identified in young adults aged 20-49 years. A reduction in CVD mortality was identified in all regions of Brazil, except for individuals aged 20-24 years, residing in the Northeast region, which showed an increase (APC: 2.45%) (p<0.05) 2013 -2017. The greatest variation in the mortality trend occurred in the South region (APC: -25.2%). While the smallest change in mortality trend occurred in the Northeast region (APC: -8.8%). The annual decline was smaller in the second quinquennium (2013-2017) compared to the first (2008-2012). Furthermore, the decline was more pronounced among women (APC: -2.51%) (p<0.05) 2008-2012 and in young adults aged 40-44 years (APC: -2.91%) (p<0.05) 2008-2012. Furthermore, the trend in CVD mortality stabilized from 2013 onwards in males (p>0.05).

Conclusion

the results demonstrate a decreasing trend in mortality from Cardiovascular Disease in young adults in Brazil, between 2008-2017. It is concluded that there is inequality in the trend of mortality from CVD according to sex, age group and regions of Brazil.

Key words: cardiovascular diseases; epidemiology; mortality; young adult

Síntese dos autores

Por que este estudo foi feito?

Estudos epidemiológicos de base populacional sobre mortalidade por causa específica permitem direcionar políticas públicas para o risco populacional. Poucos estudos abordam sobre como diferenças regionais atribuídas à fatores socioeconômicos afetam a mortalidade por Doenças Cardiovasculares em populações mais jovens. Análises detalhadas das tendências de mortalidade por DCV podem ajudar a identificar fatores determinantes e, portanto, destacar subgrupos populacionais, os quais são risco para desenvolver doenças crônicas além de poder beneficiar o tratamento e prevenção direcionada.

O que os pesquisadores fizeram e encontraram?

Foi realizado um estudo ecológico de séries temporais com uso de dados secundários oficiais dos Sistemas de Informações sobre Mortalidade (SIM). Foram consideradas 294.232 mortes por doenças cardiovasculares pela Classificação Internacional de Doenças (I00-I-99) em adultos jovens com idade entre 20-49 anos, residentes no Brasil, no período de 2008 a 2017. Há uma tendência decrescente da mortalidade por Doença Cardiovascular (DCV) em adultos jovens no Brasil. Além disso, identificou-se uma diferença regional na mortalidade segundo regiões do Brasil. Ademais, a mortalidade no sexo feminino declinou em ambos os períodos nas regiões Centro-Oeste e Sul, enquanto a mortalidade permaneceu estacionária nas regiões Norte, Nordeste e Sudeste no período (2013-2017), onde nesse período a tendência de mortalidade se estabilizou para ambos os sexos nas regiões Norte e Nordeste. Obteve-se aumento somente na região Nordeste com idade entre 20-24 anos, período (2013-2017).

O que essas descobertas significam?

Os achados contribuem para o planejamento e gestão do sistema de Atenção Primária à Saúde. O jovem brasileiro não deveria evoluir para morte por DCV, pois a sua capacidade vital é superior em relação ao idoso. Medidas de detecção precoce dos fatores causais contribuirão para redução das mortes.

Palavras-Chave: doenças cardiovasculares; epidemiologia; mortalidade; adulto jovem

Resumo

Introdução

doenças Cardiovasculares são as principais causas de morte no mundo. Apesar da redução da incidência e mortalidade por DCV no século XX, os valores permanecem elevados no século XXI. No Brasil, há lacuna de estudos populacionais que estimaram as taxas padronizadas de mortalidade por doenças cardiovasculares em adultos jovens.

Objetivo

avaliar a tendência da mortalidade por doenças cardiovasculares em adultos jovens, segundo sexo, faixa etária e regiões do Brasil.

Método

estudo de séries temporais com uso de dados secundários oficiais dos Sistemas de Informações sobre Mortalidade (SIM). Foram consideradas todas as mortes por doenças cardiovasculares (I00-I-99) em adultos jovens faixa etária 20-49 anos, residentes no Brasil, no período de 01 de janeiro de 2008 a 31 de dezembro de 2017. Os dados foram extraídos do Departamento de Informática do SUS (DATASUS). Foi utilizado o modelo de regressão Prais-Winsten e calculada a Variação Percentual Anual (VPA). Todas as análises foram realizadas no software STATA 14.0.

Resultados

durante período 2008-2017, foram identificadas 294.232 mortes (8,7%) por doença cardiovascular em adultos jovens com idade entre 20-49 anos. Identificou-se a redução da mortalidade por DCV em todas as regiões do Brasil, exceto nos indivíduos de 20-24 anos, residentes na região Nordeste, a qual apresentou aumento (VPA: 2,45%) (p<0,05) 2013-2017. A maior variação da tendência de mortalidade ocorreu na região Sul (VPA: -25,2%). Enquanto a menor variação de tendência da mortalidade ocorreu na região Nordeste (VPA: -8,8%). O declínio anual foi menor no segundo quinquênio (2013-2017) em comparação ao primeiro (2008-2012). Além disso, o declínio foi mais acentuado entre as mulheres (VPA: -2,51%) (p<0,05) 2008-2012 e em adultos jovens com idade entre 40-44 anos (VPA: -2,91%) (p<0,05) 2008-2012. Ademais, a tendência de mortalidade por DCV se estabilizou a partir de 2013 no sexo masculino (p>0,05).

Conclusão

os resultados demonstram tendência decrescente da mortalidade por Doença Cardiovascular em adultos jovens no Brasil, entre 2008-2017. Conclui-se que existe desigualdade na tendência de mortalidade por DCV segundo sexo, faixa etária e regiões do Brasil.

Palavras-Chave: doenças cardiovasculares; epidemiologia; mortalidade; adulto jovem

INTRODUCTION

Cardiovascular Diseases (CVD) are the leading causes of death in the world, especially in high- and middle-income countries, such as Brazil. According to the World Health Organization (WHO)1, cardiovascular diseases recorded 15 million deaths in 2015, representing 26.5% of total deaths worldwide. It follows that 8.76 million (58.4%) were due to ischemic heart disease and 6.24 (41.6%) million were due to Cerebral Vascular Accident (CVA). These diseases remained the leading causes of death during the total period between the years 2008-2017.

Studies on temporal trends of the main risk factors for cardiovascular disease in Brazil have shown a reduction in the habit of smoking, but an increase in the prevalence of overweight, obesity, unhealthy eating habits and low physical activity in the general population2. However, the incidence of cardiovascular disease in young adults increased or remained stationary. Furthermore, there is a new epidemic of cardiovascular disease in younger populations, especially with heart failure3.

Analyzing the trends in mortality from CVD, Ischemic Heart Disease (IHD) and Cerebral Vascular Accident (CVA), they found that in the period 1980-2012 there was a reduction in mortality from these three disease groups in men and women, while the trend in mortality from IHD stopped declining in Brazil in the period 2007-20124. In addition, mortality adjusted for race, sex and socioeconomic factors tends to decline in individuals with black skin color and low income2.

In Brazil, CVD also represents the main causes of death in the population, accounting for 27.6% in 2015. However, proportional mortality differs when analyzing specific regions of the country. The proportional mortality from CVD in the North region is 22.9%, while in the South region, these diseases accounted for 28% of all deaths5. Furthermore, the two main groups of deaths from CVD were Coronary Artery Disease (CAD) and Cerebral Vascular Accident (CVA), which is subdivided into two groups Hemorrhagic Cerebrovascular Accident (CVA) and Ischemic Cerebral Vascular Accident (CVA), totaling 31.9% and 28.7%, respectively, due to CVD in Brazil3.

The Brazilian study identified a decline in stroke hospitalizations and mortality and a stationary trend for stroke for the developed regions of Brazil. The period (2011–2018) showed an increase in hospitalizations for stroke in both regions and genders. Mortality for stroke and stroke decreased between 2008–2018 in southeastern and southern Brazil for both gender6.

Data on all deaths in Brazil are recorded in the Mortality Information System (SIM), which provides the calculation for mortality statistics, including causes of death, contained in the International Classification of Diseases in its tenth revision (ICD-10) since 1996. National coverage is estimated at 96% of all deaths in the country. In addition, the reliability and completeness of information are favorably analyzed in the national context7.

Worldwide, the reduction in mortality from CVD was described from the 50’s onwards8. However, the values still remain high in industrialized countries at the beginning of the 21st century. In Brazil, this reduction has been observed since the 70s9. An analytical study of time series of mortality ratios for Chronic Noncommunicable Diseases (NCDs) showed a significant reduction in CVD mortality in men in the southern states, while a small reduction was found in the states of the North region of Brazil8-10.

Although there is a significant increase in CVD studies in developed countries, there is still a gap on how regional differences attributed to socioeconomic factors affect mortality from cardiovascular diseases in younger populations. Detailed analyzes of CVD mortality trends can help to identify determinants and, therefore, highlight population subgroups, which are at risk for developing chronic diseases and which may benefit from targeted treatment and prevention.

Evidence for researchers who addressed and considered socioeconomic factors and interurban differences showed a high mortality ratio for CVD in populations with low socioeconomic status11,12. In addition, higher education is related to quality of life and is capable of improving health promotion, with a better response to educational campaigns12.

Countries with a population of at least 100 million inhabitants are: China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia, Japan and Mexico, with significant social inequalities representing more than 60% of the world population. Everyone is facing an epidemic of chronic non-communicable diseases (NCDs), where high cholesterol, obesity, diabetes and cardiovascular diseases are becoming major public health problems13.

In an analysis of morbidity and mortality from Cerebral Vascular Accident (CVA) (a subtype of cardiovascular disease) among young Brazilian adults, using secondary data from the Hospital and Mortality Information Systems, they identified a decrease in mortality, mainly in individuals over 30 years, and incidence stability; and also regional variation in stroke-related morbidity and mortality among young Brazilian adults in the period 2008-201214.

Population-based epidemiological studies on cause-specific mortality allow directing public policies towards population risk. In addition, in Brazil, Health Information Systems have been used as a tool for health diagnosis to address the epidemiological profile, identifying priorities, planning and refining actions15.

Thus, the objective is to evaluate the trend in mortality from Cardiovascular Diseases, in individuals aged between 20 and 49 years, and to estimate the annual percentage change in mortality rates, according to sex, age group and regions of Brazil, in the period 2008-2017.

METHODS

Study Design

This is an ecological study with a time series design using secondary data on deaths from Cardiovascular Diseases of residents in Brazil, from the Mortality Information System (SIM).

Study Location and Period

Secondary data correspond to the period from January 1, 2008 to December 31, 2017. The information came from Brazil with an estimated population of 211 million inhabitants and an estimated population of 88 million inhabitants aged between 20 and 49 years (2008-2017) – Brazilian Institute of Geography and Statistics (IBGE 2020)16. It covers 8.5 million km2, occupying 47% of the territory of South America and the 6th place in the world in terms of population. Brazil is a federative republic with continental dimensions and social and regional inequalities. The country has a high Human Development Index (HDI) of 0.755, 75th in the world ranking (Human Development Report 2015) and is considered one of the four main emerging economies that will dominate in the 21st century17.

Study Population and Eligibility Criteria

Mortality was accounted for by deaths due to Cardiovascular Disease, which were recorded by SIM, according to age groups defined by a previous study that described the Epidemiology of Cardiovascular Disease in young adults, considering the age group between 18-45 years3. In addition, the World Health Organization (WHO) has not found adolescents aged between 10-19 years. Thus, for this study, we considered the population aged between 20-49 years as young adults18.

Data Collection

All data were collected by place of residence through files provided by the Department of Informatics of the Unified Health System (DATASUS)7 and maintained by the Brazilian Ministry of Health. We considered all deaths in individuals aged between 20 and 49 years in Brazil, whose underlying cause was classified as Cardiovascular Disease according to the tenth Revision of the International Classification of Diseases (ICD-10), I00 - I99.

Developed and implemented by the Brazilian Ministry of Health, the Health Information System (SIS) has made it necessary to increase regional management tools and gradually consolidate and qualify them19,20.

SIM was implemented in 1977 and death data have been in the public domain since 1979, with important and necessary information for mortality statistics, including underlying cause of death21. The causes of death declared by physicians were coded according to the standards established by the World Health Organization by the ICD-10. An increase in coverage and confidence was observed in the years 2008 to 201722,23.

The mortality rate was based on data collected by the population residing in Brazil provided by the Brazilian Demographic Census 2010 and also on intercensus projections for the other years (2008-2017), according to information provided by DATASUS.

Data Analysis

We use compressed files to extract the information tabulated in TABNET. This System provides information contained in the Death Certificate (DO) (standardized instrument through the collection of information from the SIM). In addition, we use the TABWIN software that allows tabulation and processing of data.

For the mortality time series, two-time intervals of 5 consecutive years were used (2008-2012 and 2013-2017), according to sex, age group and regions using the Prais-Winsten regression model. This stratification procedure of 2 consecutive 5-year periods ensured a sufficient number of deaths providing stability to identify statistically significant differences. In addition, the Durbin-Watson test was used, which allows scaling the existence of first-order autocorrelation of the time series composed of annual rates. Furthermore, the following were estimated: angular coefficient (β) respective probability (p); Annual Percentage Change (APC), and the 95% Confidence Interval (CI).

The statistical analysis process included data processing, transforming the standardized rates into a logarithmic function of base 10. The Annual Percentage Variation (APV), according to age group and geographic groups, were calculated with the respective confidence interval (CI 95%). With this procedure it is possible to classify the increasing, decreasing or stationary trend. The trend was considered stationary when the coefficient was not significantly different from zero (p<0.05)24. In order to visualize the trends, a graph was built to present the historical series according to regions of Brazil. All analyzes were used using Stata 14.0 software (CollegeStation, TX, 2013).

Ethical and Legal Aspects of the Research

The present study only involves the description and analysis of secondary data: from the population, not being obtained information that identifies the individuals. In addition, all information collected is in the public domain. Therefore, this study does not require approval from the Ethics and Research Committee (CEP), in accordance with Resolution no. 510/2016, of April 7, 2016, of the National Health Council, pursuant to Law no. 2011.

RESULTS

During the period 2008-2017, 294,232 deaths from cardiovascular disease were identified in young Brazilian adults aged 20-49 years, corresponding to 8.9% of deaths from CAD. It was evidenced that deaths from cardiovascular diseases in men were higher (60.4%) than in women (39.6%). The highest mortality trend was found in the 40-49 age group (66.2%), with 4 to 7 years of schooling (25.3%). Non-white race/color (ie, black and brown) corresponded to 54.8% of total deaths. The highest mortality trend was found in single marital status (48.5%) (table 1).

Table 1 : Distribution of Mortality from Cardiovascular Diseases (x 100,000 inhabitants), in young adults aged between 20 and 49 years, Brazil, 2008-2017 

Demographic characteristics Deaths (N= 294232) Proportional Mortality (%)
Gender
Male 177602 60.36
Female 116612 39.64
Total 294214 100
Age group (years old)
20 a 24 10201 3.43
25 a 29 15736 5.28
30 a 34 26630 8.94
35 a 39 44553 14.96
40 a 44 75486 25.35
45 a 49 121626 40.85
Total 294232 100
Schooling
None 22043 7.43
1-3 54590 18.34
4-7 75296 25.30
8-11 58245 19.56
≥ 12 17214 5.78
Total 227537 100
Race
White 118043 39.84
Black 34574 11.54
Brown 128619 43.24
Yellow skin 821 0.28
Indigenous 641 0.21
Total 279852 100
Marital status
Single 142.768 48.49
Married 93.396 31.72
Widower 6.258 2.11
Divorced 17.657 6.00
Others 12.452 4.23
Total 272338 100

Source: Sistema de Informações sobre Mortalidade (SIM/SUS); Available at: http://datasus.saude.gov.br/; Viewed: 02/09/2019.

N- Represents the absolute number of deaths and (%) represents the proportion;

There is a trend towards a reduction in mortality from CVD in all regions of Brazil between the period 2008-2017. The greatest variation in mortality occurred in the South region (APC: -25.2%). While the smallest variation in mortality occurred in the Northeast region (APC: -8.8%). In addition, in 2017, the mortality trends of the Northeast and Southeast regions were higher than the national mortality (30.5 x 100,000 inhabitants), while the North, South and Center-West regions presented lower rates (table 2).

Table 2 : Trends in Mortality from Cardiovascular Disease in Young Adults, according to macro-regions of Brazil, year by year, in the period 2008-2017 

Mortality 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Mean
Brazil Deaths 30485 29665 29796 30053 29350 29306 29013 29100 29525 27921 33.49
Population 87449343 88560402 88825414 89597095 90356812 91122511 91888210 92653909 93419608 94185307
Mortality 36,6 35,0 34,5 34,5 33,4 33,1 32,5 32,3 32,5 30,5
North Deaths 1660 1696 1706 1661 1687 1707 1811 1808 1834 1777 27.13
Population 6687018 6843630 7091313 7200621 7309928 7419236 7528543 7637851 7747158 7856466
Mortality 29,1 28,6 27,3 26,4 26,2 26,3 27,4 27,1 27,0 25,9
Northeast Deaths 7889 7809 7795 8113 8040 7942 7969 7979 8190 8016 35,33
Population 23775948 23931900 24087852 24243805 24399757 24555709 24711661 24867614 25023566 25179518
Mortality 37,4 36,3 34,9 36,1 35,5 34,8 34,7 34,4 35,1 34,1
Southeast Deaths 14670 14149 14311 14249 13879 13833 13600 13836 13969 12948 35,83
Population 37737283 37972083 38206884 38441684 38676485 38911285 39146086 39380886 39615686 39850487
Mortality 39,1 37,2 37,4 37,0 35,8 35,4 34,5 34,9 35,0 32,2
South Deaths 3920 3793 3719 3793 3496 3538 3339 3323 3376 3100 27,39
Population 12777738 12805140 12832542 12859944 12887346 12914748 12942150 12969551 12996953 13024355
Mortality 30,1 28,8 28,2 28,5 26,2 26,3 24,7 24,4 24,7 22,5
Midwest Deaths 2346 2218 2266 2239 2249 2287 2299 2159 2157 2082 32,88
Population 6590578 6705837 6821096 6936354 7051613 7166872 7282131 7397389 7512648 7627907
Mortality 37,5 34,4 34,1 33,1 33,1 33,1 32,9 30,9 30,6 29,1

Source: Sistema de Informações sobre Mortalidade (SIM/SUS) – Available at: http://datasus.saude.gov.br/ - Viewed: 15/01/2020

We identified that in the North region 2008-2017 there was a reduction from 29.1 to 25.9; in the Northeast region, there was a reduction from 37.4 to 34.1; in the Southeast region 2008-2017 there was a reduction from 39.1 to 32.2; in the South region 2008-2017 there was a reduction from 30.1 to 22.5; in the Midwest region 2008-2017 there was a reduction from 37.5 to 29.1. However, the decline observed in all years, in all regions, did not occur between 2010-2011, only in the South region. In this period, mortality trends ranged from 28.2 to 28.5 x 100,000 inhabitants (table 2).

Figure 1 shows the distribution curves of mortality from CVD in young adults, according to regions of Brazil, 2008-2017.

Source: author himself.

Figure 1 : Mortality from Cardiovascular Diseases in young adults, according to macro-regions in Brazil, in the period 2008-2017 

The mortality trends of the Northeast and Southeast regions showed similar behavior in the second period (2013-2017), with small variations during the global period. Furthermore, between the years 2016-2017, it is noted that in the Southeast region there is a reduction in this trend, compared to the Northeast region (35.0 to 32.2 x 100,000 inhabitants) (table 2).

Mortality trends in the North and South regions showed similar behavior in the first period (2008-2012), except between 2010-2011 when there was a slight increase in the South region. In addition, in the second period, there was also a reduction in the mortality trend in the South region, ranging from 24.7 to 22.5 x 100,000 inhabitants (table 2).

In Brazil, a reduction in mortality trends was identified for men with APC of -1.48% and for women of -2.51% in the first five years (2008-2012). In the second five-year period (2013-2017) with a APC of 1.40% for men and 1.93% for women. When analyzing the age group variable in individuals aged 35-49 years in the first five-year period (2008-2012), the APC ranged from 1.74% to 2.91%. During the second five-year period (2013-2017) in the age group between individuals aged 25-29 years, there was a reduction in the mortality trend with APV of 0.99% and for the age group of 40-49 years it varied between APV of 1.84 % and 2.23% and in all other variables not mentioned, remained stationary (table 3).

Table 3 : Mortality trends from Cardiovascular Disease in young adults aged between 20-49 years, according to sex and age groups in Brazil (2008-2017) 

Types of Cardiovascular Disease β APC % (CI 95%) Trend β APC % (CI 95%) Trend β APC % (CI 95%) Trend
Period of 2008-2012 Period of 2008-2017 Period of 2008-2017
Brazil (Gender)
Male -0,01 -1,48 (-2,82 : -0,12) Decreasing -0,01 -1,68 (-3,41 : 0,08) Stationary -0,01 -1,40(-1,77 : -1,03) Decreasing
Female -0,01 -2,51 (-3,64 : -1,36) Decreasing -0,01 -1.20 (-3,55) Decreasing -0,01 -1,93 (-2,46 : -1,40) Decreasing
Total -0,01 -1,37 (-2,95 : -0,69) Decreasing -0,01 -2,28 (-3,17 : 0,20) Stationary -0,01 -1,37 (-1,83 : -1,14) Decreasing
Brazil (Age group - years old)
20 – 24 -0,01 -0,69 (-3,48 : 2,19) Stationary 0,01 0,71 (-0,85 : 2,30) Stationary -0,01 -0,30 (-0,89 : 0,29) Stationary
25 – 29 0,00 0,07 (-2,16 : 2,36) Stationary -0,01 -1,56 (-5,71 : 2,78) Stationary -0,01 -0,99 (-1,88 : -0,10) Decreasing
30 – 34 -0,01 -0,31 (-2,03 : 1,43) Stationary -0,01 -2,96 (-8,51 : 2,92) Stationary -0,01 -1,04 (-2,54 : 0,48) Stationary
35 – 39 -0,01 -1,86 (-3,67 : -0,02) Decreasing -0,01 -0,50 (-3,48 : 2,58) Stationary -0,01 -0,75 (-1,54 : 0,04) Stationary
40 – 44 -0,01 -2,91 (-4,80 : -0,98) Decreasing -0,01 -1,03 (-2,28 : 0,24) Stationary -0,01 -2,23 (-2,90 : -1,56) Decreasing
45 – 49 -0,01 -1,74 (-3,13 : -0,33) Decreasing -0,01 -1,96 (-2,88 : -1,04) Decreasing -0,01 -1,84 (-2,08 : -1,60) Decreasing

Source: Sistema de Informações sobre Mortalidade (SIM) e Sistema de Informações Hospitalares (SIH / SUS). Data from the Departamento de Informática do Sistema Nacional de Saúde (DATASUS - www.datasus.gov.br). Ministry of Health. Brazil

β - regression coefficient; APC - Annual Percent Change (%); – Confidence Interval 95%; p Value – probability of statistics signific.

In the first five years (2008-2012), for the gender variable, the North Region showed a reduction in the mortality trend for men with APC of -2.95%; the Northeast Region in women with a APC of -2.12%. When analyzing the age group variable, the North Region in individuals aged 35-49 years with APC ranging from -1.53% to -4.50%; the Northeast Region among individuals aged 40-44 years with a APC of -2.85%. During the second five-year period (2013-2017), the Northeast Region in individuals aged 20-24 years, there was a significant increase of +2.45% and in all other variables not mentioned, they remained stationary (table 4).

Table 4 : Trends in mortality from Cardiovascular Disease, in young adults, according to selected variables, macro-regions of Brazil, 2008-2017 

Types of Cardiovascular Disease Beta (CI 95%) APC % (IC 95%) Trend Beta (CI 95%) APC % (IC 95%) Trend
Period of 2008-2012 Period of 2013-2017
North (Gender)
Homens -0,01 (-0,03 : -0,01) -2,95 (-5,79 : -0,03) Decreasing -0,01 (-0,02 : 0,01) -1,08 (-5,15 : 3,18) Stationary
Mulheres -0,01 (-0,04 : 0,01) -2,69 (-8,14 : 3,09) Stationary 0,01 (-0,01 : 0,01) 0,02 (-1,77 : 1,85) Stationary
North (Age group - years old)
20-24 -0,01 (-0,02 : 0,01) -0,69 (-3,48 : 2,19) Stationary 0,00 (-0,01 : 0,00) 0,71 (-0,85 : 2,30) Stationary
25-29 0,00 (-0,01 : 0,01) 0,07 (-2,16 : 2,36) Stationary -0,01 (-0,03 : 0,01) -1,56 (-5,71 : 2,78) Stationary
30-34 0,01 (-0,01 : 0,02) 1,93 (-1,78 : 5,79) Stationary -0,01(-0,06 : 0,05) -1,58 (-13,23: 11,64) Stationary
35-39 -0,02 (-0,03 : -0,01) -4,50 (-6,83 : -2,11) Decreasing -0,01 (-0,02 : 0,02) -0,29 (-4,08 : 3,64) Stationary
40-44 -0,01 (-0,01 : -0,01) -1,53 (-2,85 : -0,19) Decreasing 0,00 (-0,01 : 0,02) 1,61 (-1,79 : 5,12) Stationary
45-49 -0,02 (-0,03 : -0,01) -4,30 (-6,43 : -2,11) Decreasing -0,01 (-0,02 : 0,01) -1,35 (-4,77 : 2,20) Stationary
Northeast (Gender)
Male -0,01 (-0,01 : 0,01) -0,38 (-3,19 : 2,51) Stationary 0,00 (-0,01 : 0,01) 0,21 (-1,74 : 2,19) Stationary
Female -0,01 (-0,01 : 0,01) -2,12 (-3,33 : -0,88) Decreasing -0,01 (-0,02 : 0,01) -0,60 (-4,00 : 2,92) Stationary
Northeast (Age group - years old)
20-24 -0,01 (-0,03 : 0,02) -0,76 (-5,65 : 4,38) Stationary 0,01 (0,00 : 0,02) 2,45 (0,13 : 4,84) Increasing
25-29 0,01 (-0,01 : 0,03) 2,75 (-1,46 : 7,15) Stationary -0,01 (-0,03 : 0,01) -1,59 (-5,70 : 2,71) Stationary
30-34 0,01 (-0,01 : 0,02) 1,26 (-2,79 : 5,49) Stationary -0,01 (-0,05 : 0,02) -3,26 (-10,09 : 4,08) Stationary
35-39 -0,01 (-0,02 : 0,01) -0,98 (-4,39 : 2,56) Stationary 0,00 (-0,01 : 0,02) 1,03 (-2,06 : 4,21) Stationary
40-44 -0,01 (-0,02 : -0,01) -2,85 (-4,66 : -1,02) Decreasing 0,00 (-0,01 : 0,01) 0,15 (-3,00 : 3,40) Stationary
Southeast (Gender)
Male -0,01 (-0,01 : -0,01) -1,48 (-2,24 : -0,71) Decreasing -0,01 (-0,02: -0,01) -2,07 (-4,07 : -0,03) Decreasing
Female -0,01 (-0,02 : -0,01) -2,10 (-3,92 : -0,25) Decreasing -0,01(-0,02 : 0,01) -1,15 (-5,17 : 3,04) Stationary
Southeast (Age group - years old)
20-24 -0,01 (-0,03 : 0,03) -0,03 (-5,95 : 6,27) Stationary 0,01 (-0,03 : -0,03) -2,07 (-4,07 : -0,03) Decreasing
25-29 -0,01 (-0,01 : 0,00) -0,95 (-2,94 : 1,08) Stationary -0,01 (-0,03 : 0,02) -1,22 (-7,07 : 5,00) Stationary
30-34 -0,01 (-0,02 : 0,01) -1,62 (-4,68 : 1,54) Stationary -0,01 (-0,03 : 0,01) -1,22 (-7,07 : 5,00) Stationary
35-39 -0,01 (-0,01 : -0,01) -1,69 (-3,33 : -0,02) Decreasing -0,01 (-0,02 : 0,01) -1,14 (-4,43 : 2,27) Stationary
40-44 -0,01 (-0,02 : -0,01) -2,51 (-4,34 : -0,64) Decreasing -0,01 (-0,02 : 0,01) -1,51 (-4,42 : 1,50) Stationary
45-49 -0,01 (-0,02 : 0,00) -1,39 (-3,70 : 0,98) Stationary -0,01 (-0,02 -0,01) -2,07 (-3,43 : -0,69) Decreasing
South (Gender)
Male -0,01 (-0,02 : 0,00) -1,89 (-4,15 : 0,43) Stationary -0,01 (-0,02: -0,01) -2,91 (-5,56 : -0,20) Decreasing
Female -0,02 (-0,03 : -0,01) -3,61 (-6,45 : -0,69) Decreasing -0,01 (-0,02: -0,01 -2,46 (-4,14 : -0,76) Decreasing
South (Age group - years old)
20-24 0,02 ( -0,02 : 0,07) 5,73 (-4,60 : 17,17) Stationary -0,01 (-0,02: 0,01) -1,21 (-4,61 : 2,32) Stationary
25-29 -0,01 (-0,07 : 0,05) -2,20 (-14,83: 12,31) Stationary 0,00 (-0,02 : 0,03) 1,07 (-5,19 : 7,75) Stationary
30-34 0,01 (-0,00 : 0,01) 1,20 (-0,04 : 2,46) Stationary -0,02 (-0,04 : 0,01) -3,62 (-9,56 : 2,71) Stationary
35-39 -0,00 (-0,01 : 0,00) -0,94 (-1.89 : 0,02) Stationary -0,00 (-0,02 : 0,02) -0,01 (-3,90 : 4,03) Stationary
40-44 -0,01 (-0,02 : -0,00) -3,21 (-5,55 : -0,80) Decreasing -0,01 (-0,03 : 0,02) -1,95 (-7,20 : 3,59) Stationary
45-49 -0,02 (-0,03 : -0.00) -3,92 (-6,78 : -0,98) Decreasing -0,02 (-0,02 :-0,02) -4,35 (-5,24 : -3,45) Decreasing
Midwest (Sexo)
Homens -0,01 (-0,02 : 0,00) -1,79 (-4,40 : 0,89) Stationary -0,01 (-0,02: -0,00) -3,15 (-5,56 : -0,67) Decreasing
Mulheres -0,02 (-0,03 : -0,01) -4,62 (-7,10 : -2,08) Decreasing -0,02 ( -0,03:-0,00) -4,28 (-7,45 : -1,00) Decreasing
Midwest (Age group - years old)
20-24 -0,01 (-0,06 : 0,05) -1,84 (-13,33: 11,17) Stationary -0,02 (-0,12 : 0,07) -5,02 (-23,39: 17,74) Stationary
25-29 -0,00 (-0,05 : 0,05) -0,50 (-11,28: 11,59) Stationary -0,04 (-0,10 : 0,02) -9,04 (-21,09 : 4,85) Stationary
30-34 -0,00 (-0,03 : 0,02) -0,79 (-6,28 : 5,03) Stationary -0,03 (-0,05 -0,01) -6,36 (-11,11 :-1,35) Decreasing
35-39 -0,02 (-0,03 : -0,02) -4,85 (-6,04 : -3,65) Decreasing -0,01 (-0,02 : 0,01) - 1,47 (-4,95 : 2,13) Stationary
40-44 -0,02 ( -0,04 : -0,00) -5,16 (-9,14 : -1,01) Decreasing -0,02 (-0,03: -0,01) -4,05 (-6,12 : -1,94) Decreasing
45-49 -0,01 (-0,02 : 0,01) -1,37 (-4,87 : 2,26) Stationary -0,01 (-0,02 -0,01) -2,88 (-3,96 : -1,79) Decreasing

Source: Sistema de Informações sobre Mortalidade (SIM). Dados do Departamento de Informática do Sistema Único de Saúde (DATASUS - www.datasus.gov.br). Ministry of Health. Brazil

APC: Variação Percentual Anual (%); IC95% - confidence interval 95%.

In the first five years (2008-2012) for the gender variable, the Southeast region showed a reduction in the mortality trend among men with APV of -1.48% and in women with APV of -2.10%; the South and Center-West regions with APC of -3.61% and -4.62% in women, respectively. When analyzing the age group variable, there was a reduction in mortality trends, the Southeast region among individuals aged 35-39 years with a APC of -1.69% and for individuals between 40-44 it was -2.51; the South region in individuals aged 40-44 with a APC of -3.21% and of 45-49 was -3.92% and the Midwest region in individuals aged 35-39 with a APC of -4.85% and aged 40-44 years, the reduction was -5.16% and in all other variables not mentioned, they remained stationary (table 4).

In the second five-year period (2013-2017) for the gender variable, a reduction in the mortality trend in men with APC of -2.07% was identified in the Southeast region; the South Region with APC of -2.91% in men and APC of -2.46% in women and for the North Region there was a reduction of -4.62% in women, men remained stationary. When analyzing the age group variable, there was a reduction in mortality trends for individuals aged 20-24 and 45-49 years for both groups, with APC of -2.07% and the South region in individuals aged 45-49 years with APC of -4.35%; the Midwest region in individuals aged 30-34 years old with a APC of -6.36%, 40-44 years old with a APC of -4.05%, 45-49 years old was -2.88% % and in all other variables not mentioned remained stationary (table 4).

DISCUSSION

Mortality from Cardiovascular Disease (CVD) in young adults had a decreasing trend in Brazil, between 2008-2017. However, the annual decline was smaller in the second period (2013-2017) compared to the first period (2008-2012). In addition, mortality from CVD has stabilized since 2013 in the total population and in males. Differences in trends were identified between men and women, age groups and regions in Brazil, with a more accentuated decline among women and in young adults with more advanced age. Similar results were found in previous studies25.

The present study identified regional variation in mortality trends from cardiovascular diseases in young adults. Our results agree with the results of a study carried out in Brazil26 that evaluated the incidence and mortality from cerebrovascular diseases, an important subtype of cardiovascular disease, in the population of young adults (ie. 15-49 years) and also observed a reduction in mortality in individuals above of 30 years with regional variation in the period between 2008-2012.

Chronic Non-Communicable Diseases (NCDs) are a major health problem and accounted for 72% of the causes of death in Brazil in 2007. Although still high, there was a 20% reduction in mortality rates due to diseases of the circulatory system and chronic respiratory system, between 1996-2007. The reduction in NCDs can be, in part, attributed to the expansion of Primary Care, improved care and reduced smoking in the last two decades27.

Early detection of hypertension and constant blood pressure measurements in the young population can inhibit the risk for coronary artery disease.

Adherence to healthy lifestyle behaviors is associated with a 66% reduction in the risk of CVD compared with none or a single behavior28.

Prospective cohort studies and randomized clinical trials have not demonstrated a benefit in the consumption of vitamin supplementation for the prevention of cardiovascular disease (CVD)29. On the other hand, increased consumption of nutrient-rich fruits and vegetables should be recommended.

Korean young adults with stage 1 and 2 hypertension compared with normal blood pressure were associated with increased risk of cardiovascular disease and subsequent events. Young adults may be at increased risk for cardiovascular disease30.

There is a need to update large prospective studies involving Brazil and other low- and middle-income countries.

Previous epidemiological studies (PURE) linking risk factors with cardiovascular disease and mortality were limited to populations from mostly high-income countries, North America, western Europe, or China. There are few forward-looking data from other low- and middle-income countries, or from other regions of the world. The Global Burden of Disease Study is a compilation of results from existing studies, but is limited by the fact that estimates are derived by combining data from multiple studies with different data collection methods and analyses, performed over different time periods. (may not reflect current patterns of risk factors) and with relatively little data from low- and middle-income countries. These are currently the best data available, but the reliability of some estimates could be improved in large prospective studies involving several countries from different continents and at different economic levels, carried out in a standardized way and simultaneously evaluating the associations of various risk factors. with incidence and mortality31.

The early control of diabetes also helps in the survival of patients, thus reducing mortality from CAD.

Factor age at onset of type 1 diabetes is an important determinant of survival as well for all cardiovascular disease and increased risk in women. The greater focus on protection is justified in people with early-onset type 1 diabetes32.

Several interventions help with smoking cessation: mass media campaigns targeting youth and adults, advice from health professionals in both primary care and hospitals, self-help programs, group therapy, telephone counseling, workplace, nicotine replacement, bupropion and varenicline. Mass media campaigns targeting established adult smokers appeared to have similar effects regardless of age, gender, ethnicity, or education33.

Chronic non-communicable diseases (NCDs) have a high mortality burden and CVD is part of this group of diseases. Individuals with low education and vulnerable are the population most affected by CVD.

Study in rural northern Ethiopia indicates that the dual mortality burden of NCDs and communicable diseases was evident. Public health intervention measures that prioritize disadvantaged NCD patients, such as those who cannot read and write, the elderly, family and non-family co-residents, can significantly reduce NCD mortality in the adult population34.

Excess fat in the liver is a concern for doctors and healthcare professionals, as unhealthy eating habits and intake of processed foods increase the chance of developing CVD.

The incidence of non-alcoholic fatty liver disease (NAFLD) diagnosis in the community of Olmsted County, Minnesota, between 1997 and 2014 increased 5-fold, primarily in young adults. NAFLD is a consequence but also a precursor of metabolic comorbidities. The incident of metabolic comorbidities attenuates the impact of NAFLD on death and cancels its impact on cardiovascular disease35.

Therefore, all these factors contribute to the planning and direction of public policies in health systems.

CVD mortality in people under 70 years of age is a concern, as they are reported as premature deaths with years of life lost annually in Brazil and Europe36.

Up-to-date information on disease trends and how it varies across countries is essential for planning an adequate health system response37.

It is necessary to consider the limitation of the use of secondary data in mortality studies, as there is some inaccuracy in the identification and recording of the underlying cause of death. We also do not have individual data, we do not know who is the case and who belongs to the control group or who has or does not have the disease, so with only statistical data we cannot make the mistake of ecological fallacy; misinterpretation that assigns responses to individual levels. However, it should be considered that the present study, concerning a developing, middle-income country with 204 million inhabitants, is one of the first studies in Brazil to use the Prais-Winsten regression model, which allows for correction of first-order autocorrelation in the analysis of series of values organized in time and allowed to evaluate the trend of mortality from ardiovascular Diseases in the younger population, in both sexes, age groups, regions in two periods of five consecutive years.

The study of mortality represents a way of understanding the Epidemiology of Cardiovascular Diseases. The data obtained from the information systems maintained by the Ministry of Health are reliable, allowing their use as a feasible tool to establish accurate data on mortality from Cardiovascular Diseases in specific populations (young adults).

The Family Health Program, launched in 1994, is an important initiative of the national strategy to reduce CVD mortality based on primary health care, covering almost 123 million individuals (63% of the Brazilian population) in 201538.

The study carried out on the increasing mortality trend in Minnesota by the US Centers for Disease Control and Prevention (CDC) from the United States in younger populations only reinforces the need to maintain surveillance at the municipal, state and national levels39.

The metabolic risk factor was responsible for 52.4% of cardiovascular outcomes in Chinese young adults, with hypertension being the biggest risk factor40.

CONCLUSION

The results demonstrate a decreasing trend in mortality from Cardiovascular Disease (CVD) in young adults in Brazil, between 2008-2017. However, the annual decline occurred only in the first period (2008-2012), while from 2013 onwards, the trend remained stationary only for males.

In addition, a regional difference in CVD mortality was identified according to regions of Brazil. Furthermore, mortality in females declined in both periods in the Central-West and South regions, while mortality remained stationary in the North, Northeast and Southeast regions in the most recent period. In the most recent period (2013-2017) the mortality trend has stabilized for both sexes in the North and Northeast regions.

Cardiovascular disease increased only in the Northeast region, in individuals aged 20-24 years in the second five-year period (2013-2017).

The results suggest that the Brazilian epidemiological transition is not homogeneous for CVD mortality. Young Brazilians should not be hospitalized and progress to death from CVD, as their vital capacity is higher than that of the elderly, a population that is more susceptible to developing CVD. Early detection measures in the causal factors: physical activity practice; weight and overweight measurements; waist-hip measurement; blood pressure control; control of Diabetes Mellitus; diet and life habits will contribute to the reduction of deaths. These findings contribute to the planning and management of the health care system in the country, being the great challenge of Public Health for the next generations.

Acknowledgements

We would like to thank the Fundação de Amparo à Pesquisa e Inovação do Espírito Santo – FAPES, for its financial support for the execution of this project, through public notice 04/2022- PROGRAM TO SUPPORT EMERGENT CAPIXABAS GRADUATION PROGRAMS – PROAPEM.

REFERENCES

1. World Health Organization [homepage na Internet]. Cardiovascular disease. Avaliable from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases- (cvds)Links ]

2. Ribeiro ALP, Duncan BB, Brant LCC, Lotufo PA, Moinho JG, Barreto SM. Saúde Cardiovascular no Brasil: Tendências e Perspectivas. Circulation. 2016; 133(4): 422-33. DOI: http://dx.doi.org/10.1161/circulationaha.114.008727Links ]

3. Andersson C, Vasan, R. Epidemiology of cardiovascular disease in young individuals. Nature Reviews. Cardiology. 2017; 15(4): 230-240. DOI: https://doi.org/10.1038/nrcardio.2017.154Links ]

4. Mansur AP, Favarato, D. Tendências da Taxa de Mortalidade por Doenças Cardiovasculares no Brasil, 1980-2012. Arquivo Brasileiro de Cardiologia. 2016; 107(1): 20-25. DOI: 10.5935/abc.20160077 [ Links ]

5. Ministério da Saúde. Brasil. [homepage na Internet]. Painéis Saúde Brasil: mortalidade geral - causas de óbito. Avaliable from: http://svs.aids.gov.br/dantps/centrais-de-conteudos/paineis-de-monitoramento/saude-brasil/mortalidade-geral/Links ]

6. de Moraes Bernal H, de Abreu LC, Pinheiro Bezerra IM, Adami F, Takasu JM, Ji Young Suh JV, et. al. Incidência de hospitalização e mortalidade por acidente vascular cerebral em adultos jovens, residentes em regiões desenvolvidas do Brasil, 2008-2018. PLOS ONE. 2020; 15(11): e0242248. DOI: https://doi.org/10.1371/journal.pone.0242248Links ]

7. Ministério da Saúde. Brasil. [homepage na Internet]. DATASUS: Departamento de Informática do Sistema Único de Saúde. Acesso à Informação - Tabnet - Estatísticas Vitais. [ Links ]

8. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation. 2004; 110(5): 522-7 DOI: 10.1161/01.CIR.0000136993.34344.41 [ Links ]

9. Santos JD, Meira KC, Camacho AR, Salvador PTCO, Guimarães RM, Pierin ÂMG, et al. Mortalidade por infarto agudo do miocárdio no Brasil e suas regiões geográficas: análise do efeito da idade-período-coorte. Ciência & Saúde Coletiva. 2018; 23(5):1621-1634. DOI: 10.1590/1413-81232018235.16092016 [ Links ]

10. Alves CG, Morais Neto OL. Tendência da mortalidade prematura por doenças crônicas não transmissíveis nas unidades federativas brasileiras. Ciência & Saúde Coletiva. 2015; 20(3): 641-654. DOI: 10.1590/1413-81232015203.15342014 [ Links ]

11. Medeiros CR, Meneghel SN, Gerhardt TE. Inequalities in mortality from cardiovascular diseases in small municipalities. Ciência & Saúde Coletiva. 2012; 17(11): 2953-2962. DOI: 10.1590/s1413-81232012001100012 [ Links ]

12. Ishitani LH, FrancoII GC; PerpétuoIII IHO; França E. Desigualdade social e mortalidade precoce por doenças cardiovasculares no Brasil. Revista da Saúde Pública. 2006; 40(4): 684-691. DOI: 10.1590/S0034-89102006000500019 [ Links ]

13. Barquera S, Pedroza-Tobias A., Medina C. Cardiovascular diseases in mega-countries: the challenges of the nutrition, physical activity and epidemiologic transitions, and the double burden of disease. Current Opinion Lipidology. 2016; 27(4): 329-344. DOI: 10.1097/MOL.0000000000000320 [ Links ]

14. Adami F, Figueiredo FW, Paiva LS; Sa TH, Santos EF, Martins BL, Valenti, VE, Abreu LC. Mortalidade e Incidência de Internações Hospitalares por AVC entre Brasileiros de 15 a 49 Anos entre 2008 e 2012. PLoS One. 2016; 11(6): e0152739. DOI: 10.1371/journal.pone.0152739 [ Links ]

15. Lima KWS, Antunes JLF, Silva ZP. Percepção dos gestores sobre o uso de indicadores nos serviços de saúde. Saude Soc. 2015; 24(1): 61-71. DOI: 10.1590/S0104-12902015000100005 [ Links ]

16. Instituto Brasileiro de Geografia e Estatística [homepage na Internet]. Cidades e Estados. Avaliable from: https://www.ibge.gov.br/cidades-e-estadosLinks ]

17. PNUD Brasil [homepage na Internet]. Relatório do Desenvolvimento Humano 2019. Avaliable from: https://www.br.undp.org/content/brazil/pt/home/presscenter/articles/2019/pnud-apresenta-relatorio-de-desenvolvimento-humano-2019-com-dado.htmlLinks ]

18. Barreto SM, Passos VMA, GIatti L Comportamento saudável entre adultos jovens no Brasil. Revista de Saúde Pública. 2009; 43 (2): 9-17. DOI: 10.1590/S0034-89102009000900003 [ Links ]

19. Coelho Neto GC, Chioro A. Afinal, quantos Sistemas de Informação em Saúde de base nacional existem no Brasil? Cadernos de Saúde Pública. 2021; 37(7): e00182119. DOI: 10.1590/0102-311X00182119 [ Links ]

20. Levy, S. Pense grande faça pequeno. Revista Brasileira de Epidemiologia. 2007; 10(1): 127-128. DOI: 10.1590/S1415-790X2007000100014 [ Links ]

21. Benedetti MSG, Saraty SB, Martins AG, Miranda MJ, Abreu DMX. Estudo de avaliação do projeto de pesquisa de códigos garbage na região Norte do Brasil. Revista Brasileira de Epidemiologia. 2019; 22(3); e19006. DOI: 10.1590/1980-549720190006.supl.3 [ Links ]

22. Laurenti R, Jorge MHPM, Lebrão ML, Gotlieb SLD, Almeida MF. Editorial Especial - Estatísticas Vitais: contando os nascimentos e as mortes. Rev Bras Epidemiol. 2005; 8(2): 108-10. DOI: 10.1590/S1415-790X2005000200002 [ Links ]

23. Paes, NA. Qualidade das estatísticas de óbitos por causas desconhecidas dos Estados brasileiros. Revista de Saúde Pública. 2007; 41(3): 436-445. DOI: 10.1590/s0034-89102007000300016 [ Links ]

24. Antunes JLFC, Alves MR. Uso da análise de séries temporais em estudos epidemiológicos. Epidemiologia e Serviços de Saúde. 2015; 24(3): 565-576. DOI: 10.5123/S1679-49742015000300024 [ Links ]

25. Mansur AP, Favarato D. Mortalidade por Doenças Cardiovasculares em Mulheres e Homens nas cinco Regiões do Brasil, 1980-2012. Arquivos Brasileiros de Cardiologia. 2016; 107(2): 137-146. DOI: 10.5935/abc.20160102 [ Links ]

26. Brant LCC, Nascimento BR, Passos VMA, Duncan BB, Bensenõr IJM, Malta DC, et al. Variações e diferenciais da mortalidade por doença cardiovascular no Brasil e em seus estados, em 1990 e 2015: estimativas do Estudo Carga Global de Doença. Revista Brasileira de Epidemiologia. 2017; 20(1): 116-128. DOI: 10.1590/1980-5497201700050010 [ Links ]

27. Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Barreto SM. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. 2011; 377 (9781): 1949-1961. DOI: 10.1016/S0140-6736(11)60135-9 [ Links ]

28. Barbaresko J, Rienks J, Nöthlings U. Lifestyle indices and cardiovascular disease risk: a meta-analysis. American Journal of Preventive Medicine. 2018; 55(4): 555-564. DOI: 10.1016/j.amepre.2018.04.046 [ Links ]

29. Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis. Annals of internal medicine. 2016; 165(12): 856-866. DOI: 10.7326/M16-1165 [ Links ]

30. Son JS, Choi S, Kim K, et al. Association of blood pressure classification in korean young adults according to the 2017 American College of Cardiology/American Heart Association Guidelines with subsequent cardiovascular disease events. JAMA. 2018; 320(17): 1783-1792. DOI: 10.1001/jama.2018.16501 [ Links ]

31. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries. (PURE): a prospective cohort study The Lancet. 2020; 395 (10226): 795-808. DOI: 10.1016/S0140-6736(19)32008-2 [ Links ]

32. Rawshani A, Rawshani A, Franzén S, Sattar N, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, McGuire DK, Rosengren A, Gudbjörnsdottir S. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. 2018; 379 (7): 633-644. DOI: 10.1056/NEJMoa1800256 [ Links ]

33. Flottorp S, Farah MG, Thürmer H, Johansen M, Fretheim A. Non-pharmacological interventions to reduce the risk for cardiovascular disease: a summary of systematic reviews. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH). Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 19-2008 [ Links ]

34. Abera SF, Gebru AA, Biesalski HK, Ejeta G, Wienke A, Scherbaum V, Kantelhardt EJ. Social determinants of adult mortality from non-communicable diseases in northern Ethiopia, 2009-2015: evidence from health and demographic surveillance site. PloS One. 2017; 12 (12): e0188968. DOI: 10.1371/journal.pone.0188968 [ Links ]

35. Allen AM, Therneau TM, Larson JJ, Coward A, Somers VK, Kamath PS. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study. Hepatology (Baltimore, Md.). 2018; 67 (5): 1726-1736. DOI: 10.1002/hep.29546 [ Links ]

36. Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Epidemiology of cardiovascular disease in Europe. Nature Reviews Cardiology. 2022 Feb; 19 (2): 133-143. DOI: 10.1038/s41569-021-00607-3 [ Links ]

37. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al; GBD-NHLBI-JACC. Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: GBD 2019 Study. Journal of the American College Cardiology. 2020; 77 (15): 1958-1959. DOI: 10.1016/j.jacc.2020.11.010 [ Links ]

38. Andrade MV, Coelho AQ, Xavier Neto M, Carvalho LR, Atun R, Castro MC. Brazil's Family Health Strategy: factors associated with programme uptake and coverage expansion over 15 years (1998-2012). Health Policy and Planning. 2018; 33 (3): 368-380. DOI: 10.1093/heapol/czx189. [ Links ]

39. Manemann SM, Gerber Y, Bielinski SJ, Chamberlain AM, Margolis KL, Weston SA, Killian JM, Roger VL. Tendências recentes em mortes por doenças cardiovasculares: uma perspectiva específica do estado. BMC Saúde Pública. 1 de junho de 2021; 21(1):1031. DOI: 10.1186/s12889-021-11072-5. PMID: 34074276; PMCID: PMC8169395. [ Links ]

40. Wang T, Zhao Z, Yu X, Zeng T, Xu M, Xu Y, et al. Age-specific modifiable risk factor profiles for cardiovascular disease and all-cause mortality: a nationwide, population-based, prospective cohort study. The Lancet Regional Health - Western Pacific. 2021; 17: 100277. DOI: 10.1016/j.lanwpc.2021.100277. [ Links ]

Received: August 2022; Accepted: September 2022; Published: October 2022

Creative Commons License  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.